High-density lipoprotein-cholesterol and not HbA1c was directly related to cardiovascular outcome in PROactive.
about
PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertaintyResponse: Basal C-peptide Level as a Surrogate Marker of Subclinical Atherosclerosis in Type 2 Diabetic Patients (Diabetes Metab J 2011;35:41-9).In vivo actions of peroxisome proliferator-activated receptors: glycemic control, insulin sensitivity, and insulin secretion.Is glucose control important for prevention of cardiovascular disease in diabetes?PPARγ and Its Role in Cardiovascular Diseases.Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus?Safety of antidiabetes medications: An update.Effect of pioglitazone versus metformin on cardiovascular risk markers in type 2 diabetes.
P2860
Q27024799-EEE7CE43-7073-479D-813B-380E58449C2EQ35067262-8B593AA2-0B1A-46CC-92F0-03666DB8761BQ37577126-92CE016F-DD78-4925-9B34-CDCA436C71CEQ37577137-A95F7A68-FBF6-4883-B0FE-F3F7F53CEDDBQ37627571-8235B5B1-A9B4-44C2-8D95-837F0358D194Q38092275-C473814E-9456-4C03-AB17-BCF5B9FC967AQ38395221-814BCA3D-0176-4E95-9EAA-4B7F05982438Q51345495-A6D7B1A6-12C4-4DBA-9DED-84C23D0176D3
P2860
High-density lipoprotein-cholesterol and not HbA1c was directly related to cardiovascular outcome in PROactive.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
High-density lipoprotein-chole ...... vascular outcome in PROactive.
@en
High-density lipoprotein-chole ...... vascular outcome in PROactive.
@nl
type
label
High-density lipoprotein-chole ...... vascular outcome in PROactive.
@en
High-density lipoprotein-chole ...... vascular outcome in PROactive.
@nl
prefLabel
High-density lipoprotein-chole ...... vascular outcome in PROactive.
@en
High-density lipoprotein-chole ...... vascular outcome in PROactive.
@nl
P2093
P2860
P1476
High-density lipoprotein-chole ...... vascular outcome in PROactive.
@en
P2093
B Charbonnel
D J Betteridge
E Ferrannini
J A Dormandy
R A Defronzo
R G Wilcox
R Spanheimer
P2860
P304
P356
10.1111/J.1463-1326.2011.01404.X
P577
2011-08-01T00:00:00Z